Diane Rogers has joined Aldevron as its Senior Vice President Commercial Development. In her role, Rogers will be responsible for leading the worldwide sales and marketing activities to support Aldevron’s business units.
Fargo, N.D., based company increasing capacity to better serve
rapidly growing biotech industry
Aldevron officially broke ground on its 14-acre campus expansion at its global headquarters in Fargo, North Dakota, August 19. Three buildings are planned, with construction of its next GMP manufacturing facility starting first.
EQT to acquire majority interest in Aldevron, the leading global supplier of plasmid DNA used in cell and gene therapies
Aldevron, a global leader in antibody discovery to the biotech industry, announced today the acquisition and installation of the Beacon Optofluidic platform (Beacon) to support rapid execution of species agnostic single B-cell antibody discovery to complement its industry-leading genetic immunization and hybridoma capabilities.
The Beacon platform will be located in the recently announced expansion lab space in Aldevron’s Freiburg, Germany, facility and will be coming on-line in June 2019. Aldevron is the first CRO in Germany to adapt this new technology for antibody discovery.
Aldevron appoints presidents of its Antibody and Protein business units, strengthening its position as a global leader in biologics manufacturing
Brian Walters, President of its Antibody Business Unit, and Tom Foti now President of its Protein Business Unit
Aldevron has named Brian Walters, President of its antibody business unit and Tom Foti President of its protein business unit.
Aldevron has expanded its leadership team by appointing Michelle Berg President of its GMP nucleic acids business unit. She will report to Michael Chambers, Aldevron’s founder and CEO.
Aldevron announced today its new fermentation capacity of 1,000 liters and plans to significantly increase the Company’s manufacturing footprint in Madison, WI. The large-scale fermentation equipment is already installed and will be coming on-line in Q4 2019.
James Brown, Ph.D., presenting "Standardized Plasmids for Viral Vector Production" tech talk at American Society of Gene & Cell Therapy Annual Meeting
Representatives from Aldevron will attend the 22nd Annual Meeting for the American Society of Gene & Cell Therapy (ASGCT), April 29 - May 2, 2019, in Washington, D.C.
Dr. Victoria Sowemimo has joined Aldevron as its new Director of Quality Assurance. In her position, Sowemimo will lead the company’s cGMP Quality Assurance functions supporting through all phases of clinical and commercial product release, management of Aldevron’s quality systems and regulatory training to assure compliance to all phase appropriate requirements pertaining to Good Manufacturing Practices.
Michael Jablon of Aldevron has been named Senior Director of Information Systems. In this position, Jablon will lead Information Systems initiatives to improve efficiency, streamline operations, optimize information security and design innovative systems that will enable Aldevron’s clients to more rapidly advance treatments and gene therapies for their patients.